| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
35,620 |
32,727 |
$350K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,606 |
4,178 |
$176K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
12,673 |
11,596 |
$171K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
17,759 |
15,990 |
$103K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,904 |
2,316 |
$91K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,732 |
1,642 |
$72K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
5,970 |
5,857 |
$48K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
19,461 |
17,404 |
$37K |
| 90461 |
|
6,568 |
6,181 |
$30K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
754 |
628 |
$25K |
| 87428 |
|
1,954 |
1,923 |
$22K |
| 90686 |
|
3,696 |
3,366 |
$21K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
5,774 |
5,586 |
$19K |
| 3008F |
|
16,178 |
14,309 |
$15K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
6,881 |
6,613 |
$13K |
| 92551 |
|
7,642 |
6,660 |
$12K |
| 99174 |
|
11,924 |
10,137 |
$12K |
| 90670 |
|
275 |
274 |
$8K |
| 90698 |
|
362 |
351 |
$6K |
| 92587 |
|
1,571 |
1,381 |
$5K |
| 99188 |
|
236 |
235 |
$4K |
| 96127 |
|
5,647 |
4,917 |
$2K |
| 90674 |
|
83 |
78 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
341 |
337 |
$2K |
| 90671 |
|
96 |
83 |
$1K |
| 96161 |
|
2,647 |
2,490 |
$1K |
| 83655 |
|
450 |
405 |
$1K |
| 0072A |
|
67 |
67 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
181 |
173 |
$908.36 |
| 0071A |
|
74 |
74 |
$880.00 |
| 90716 |
|
24 |
24 |
$844.98 |
| 99051 |
|
653 |
641 |
$809.33 |
| 90651 |
|
31 |
12 |
$507.20 |
| 90656 |
|
430 |
429 |
$438.11 |
| 94760 |
|
13,151 |
12,237 |
$431.05 |
| 36416 |
|
409 |
361 |
$269.44 |
| 99050 |
|
261 |
254 |
$263.98 |
| 99215 |
Prolong outpt/office vis |
89 |
57 |
$245.42 |
| 90633 |
|
42 |
37 |
$219.50 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
25 |
25 |
$204.07 |
| 99000 |
|
7,204 |
6,794 |
$172.50 |
| 90672 |
|
14 |
13 |
$161.32 |
| 90661 |
|
96 |
96 |
$51.06 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
57 |
55 |
$45.00 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
13 |
13 |
$41.38 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
16 |
14 |
$22.50 |
| A7010 |
Corrugated tubing, disposable, used with large volume nebulizer, 100 feet |
14 |
14 |
$10.44 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
12 |
12 |
$6.81 |
| A7015 |
Aerosol mask, used with dme nebulizer |
28 |
28 |
$4.00 |
| 99072 |
|
11,395 |
10,829 |
$0.00 |
| 91307 |
|
138 |
138 |
$0.00 |
| 90680 |
|
13 |
13 |
$0.00 |